RE:RE:European Medical cannabis Like the uplisting to NASDAQ which will coincide with our entry into the US via purchase that funds have already been raised for. Remember the US is the Wild West with no rules, don't think for a second Valens hasn't been talking with MSOs about the regulations coming when US does legalize and with a US footprint and a track record leaning on safety analytics they can manufacture for MSOs who can focus on distribution and brands. Valens is the ying to MSOs yang. We are a competitor, we are a collaborator. Think about that for a second. FDA is gonna be all over existing companies to bring their protocols up to speed, why wouldn't you outsource to a company already running full out in that type of environment